{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:33:52Z","timestamp":1789576432322,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008213","name":"South Dakota State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008213","id-type":"DOI","asserted-by":"publisher"}]},{"name":"California Northstate University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.intimp.2016.07.027","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T02:19:09Z","timestamp":1470277149000},"page":"251-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy"],"prefix":"10.1016","volume":"39","author":[{"given":"Chowdhury S.","family":"Abdullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-Qiu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.07.027_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.07.027_bb0010","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association","volume":"100","author":"Grundy","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.07.027_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2016.07.027_bb0025","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehq499","article-title":"Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus","volume":"32","author":"Giubilato","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2016.07.027_bb0030","doi-asserted-by":"crossref","first-page":"596967","DOI":"10.1155\/2014\/596967","article-title":"Increased peripheral proinflammatory T helper subsets contribute to cardiovascular complications in diabetic patients","volume":"2014","author":"Zhao","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2016.07.027_bb0035","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left ventricular T cell recruitment contributes to the pathogenesis of heart failure","volume":"8","author":"Nevers","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.intimp.2016.07.027_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yexmp.2010.10.004","article-title":"Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis","volume":"90","author":"Wei","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ijmm.2013.1368","article-title":"Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis","volume":"32","author":"Becher","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2016.07.027_bb0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.yjmcc.2010.05.005","article-title":"Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy","volume":"49","author":"Haudek","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2990","article-title":"Fibrocytes: emerging effector cells in chronic inflammation","volume":"11","author":"Reilkoff","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-8703(03)00118-2","article-title":"Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate","volume":"46","author":"Deutschman","year":"2003","journal-title":"Am. Heart J."},{"key":"10.1016\/j.intimp.2016.07.027_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1194\/jlr.M010595","article-title":"Circulating sphingolipid biomarkers in models of type 1 diabetes","volume":"52","author":"Fox","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2016.07.027_bb0075","doi-asserted-by":"crossref","first-page":"H250","DOI":"10.1152\/ajpheart.00372.2015","article-title":"Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction","volume":"310","author":"Zhang","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.07.027_bb0085","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.07.027_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042900","article-title":"FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1\/3 in diabetic heart disease","volume":"7","author":"Yin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.07.027_bb0095","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1253\/circj.CJ-14-0521","article-title":"Sphingosine-1-phosphate receptor agonist FTY720 restores coronary flow reserve in diabetic rats","volume":"78","author":"Xu","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.intimp.2016.07.027_bb0100","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/bph.12621","article-title":"Inhibition of PKC-\u03b8 preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy","volume":"171","author":"Li","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0105","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.CIR.0000143632.06471.93","article-title":"Sphingosine kinase activation mediates ischemic preconditioning in murine","volume":"110","author":"Jin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.07.027_bb0110","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI116082","article-title":"Verapamil ameliorates the clinical and pathological course of murine myocarditis","volume":"90","author":"Dong","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.07.027_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1746-6148-9-123","article-title":"Multiparametruc and semiquantitative scoring systems for the evaluation of mouse model histopathology \u2013 a systematic review","volume":"9","author":"Klopfleisch","year":"2013","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.intimp.2016.07.027_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1475-2840-11-105","article-title":"Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats","volume":"11","author":"Lu","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jchromb.2011.01.015","article-title":"Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry","volume":"879","author":"Lan","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.intimp.2016.07.027_bb0130","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-\u03b2 in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2016.07.027_bb0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine 1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.intimp.2016.07.027_bb0140","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/blood-2005-07-2628","article-title":"Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720","volume":"107","author":"Zemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.07.027_bb0145","first-page":"2979","article-title":"Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells","volume":"78","author":"Graeler","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2016.07.027_bb0150","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1111\/bph.12620","article-title":"Investigation the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization","volume":"171","author":"Sykes","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2007.04.006","article-title":"Sphingosine 1-phopshate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology","volume":"115","author":"Brinkmann","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2016.07.027_bb0160","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1165\/rcmb.2009-0345OC","article-title":"Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury","volume":"43","author":"Shea","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2353\/ajpath.2007.060485","article-title":"Immunomodulator FTY720 induces myofibroblast differentiation via lysophospholipid receptor S1P3 and Smad3 signaling","volume":"170","author":"Keller","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2016.07.027_bb0170","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/STROKEAHA.113.002880","article-title":"FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection","volume":"44","author":"Kraft","year":"2013","journal-title":"Stroke"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T04:08:24Z","timestamp":1568261304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916303083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"alternative-id":["S1567576916303083"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.07.027","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}